Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 Oct;57(Suppl 2):ii57–ii63.

THE LUNG CANCER PARADOX: TIME FOR ACTION

R Rintoul, T Sethi
PMCID: PMC1766005  PMID: 12364713

Full Text

The Full Text of this article is available as a PDF (104.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K., McSharry C. P., Morris G. P., Cameron C. H., McLellan D., Vernon D. R. Pulmonary infiltration after exposure to home renovation dust: histopathology and microanalysis. Thorax. 1996 Jun;51(6):654–657. doi: 10.1136/thx.51.6.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bach P. B., Cramer L. D., Schrag D., Downey R. J., Gelfand S. E., Begg C. B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001 Jul 19;345(3):181–188. doi: 10.1056/NEJM200107193450306. [DOI] [PubMed] [Google Scholar]
  3. Clegg A., Scott D. A., Hewitson P., Sidhu M., Waugh N. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax. 2002 Jan;57(1):20–28. doi: 10.1136/thorax.57.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Connolly C. K., Crawford S. M., Rider P. L., Smith A. D., Johnston C. F., Muers M. F. Carcinoma of the bronchus in the Yorkshire region of England 1976-1990: trends since 1984. Eur Respir J. 1997 Feb;10(2):397–403. doi: 10.1183/09031936.97.10020397. [DOI] [PubMed] [Google Scholar]
  5. Damhuis R. A., Schütte P. R. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996 Jan;9(1):7–10. doi: 10.1183/09031936.96.09010007. [DOI] [PubMed] [Google Scholar]
  6. Dennie C. J., Matzinger F. R., Marriner J. R., Maziak D. E. Transthoracic needle biopsy of the lung: results of early discharge in 506 outpatients. Radiology. 2001 Apr;219(1):247–251. doi: 10.1148/radiology.219.1.r01ap11247. [DOI] [PubMed] [Google Scholar]
  7. Fry W. A., Menck H. R., Winchester D. P. The National Cancer Data Base report on lung cancer. Cancer. 1996 May 1;77(9):1947–1955. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  8. Georgoulias V., Papadakis E., Alexopoulos A., Tsiafaki X., Rapti A., Veslemes M., Palamidas P., Vlachonikolis I., Greek Oncology Cooperative Group (GOCG) for Lung Cancer Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet. 2001 May 12;357(9267):1478–1484. doi: 10.1016/S0140-6736(00)04644-4. [DOI] [PubMed] [Google Scholar]
  9. Green R. A., Humphrey E., Close H., Patno M. E. Alkylating agents in bronchogenic carcinoma. Am J Med. 1969 Apr;46(4):516–525. doi: 10.1016/0002-9343(69)90071-0. [DOI] [PubMed] [Google Scholar]
  10. Gregor A., Thomson C. S., Brewster D. H., Stroner P. L., Davidson J., Fergusson R. J., Milroy R., Scottish Cancer Trials Lung Group. Scottish Cancer Therapy Network Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax. 2001 Mar;56(3):212–217. doi: 10.1136/thorax.56.3.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haponik E. F., Shure D. Underutilization of transbronchial needle aspiration: experiences of current pulmonary fellows. Chest. 1997 Jul;112(1):251–253. doi: 10.1378/chest.112.1.251. [DOI] [PubMed] [Google Scholar]
  12. Henschke C. I., McCauley D. I., Yankelevitz D. F., Naidich D. P., McGuinness G., Miettinen O. S., Libby D. M., Pasmantier M. W., Koizumi J., Altorki N. K. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999 Jul 10;354(9173):99–105. doi: 10.1016/S0140-6736(99)06093-6. [DOI] [PubMed] [Google Scholar]
  13. Hong W. K., Nicaise C., Lawson R., Maroun J. A., Comis R., Speer J., Luedke D., Hurtubise M., Lanzotti V., Goodlow J. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group. J Clin Oncol. 1989 Apr;7(4):450–456. doi: 10.1200/JCO.1989.7.4.450. [DOI] [PubMed] [Google Scholar]
  14. Janssen-Heijnen M. L., Schipper R. M., Razenberg P. P., Crommelin M. A., Coebergh J. W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998 Aug;21(2):105–113. doi: 10.1016/s0169-5002(98)00039-7. [DOI] [PubMed] [Google Scholar]
  15. Jett J. R., Everson L., Therneau T. M., Krook J. E., Dalton R. J., Marschke R. F., Jr, Veeder M. H., Brunk S. F., Mailliard J. A., Twito D. I. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group. J Clin Oncol. 1990 Jan;8(1):33–38. doi: 10.1200/JCO.1990.8.1.33. [DOI] [PubMed] [Google Scholar]
  16. Knox A. J., Mascie-Taylor B. H., Page R. L. Fibreoptic bronchoscopy in the elderly: 4 years' experience. Br J Dis Chest. 1988 Jul;82(3):290–293. doi: 10.1016/0007-0971(88)90071-x. [DOI] [PubMed] [Google Scholar]
  17. Liu B. Q., Peto R., Chen Z. M., Boreham J., Wu Y. P., Li J. Y., Campbell T. C., Chen J. S. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ. 1998 Nov 21;317(7170):1411–1422. doi: 10.1136/bmj.317.7170.1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Macfarlane J. T., Storr A., Wart M. J., Smith W. H. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly. Age Ageing. 1981 May;10(2):127–131. doi: 10.1093/ageing/10.2.127. [DOI] [PubMed] [Google Scholar]
  19. Mountain C. F. Revisions in the International System for Staging Lung Cancer. Chest. 1997 Jun;111(6):1710–1717. doi: 10.1378/chest.111.6.1710. [DOI] [PubMed] [Google Scholar]
  20. Muers M. F., Haward R. A. Management of lung cancer. Thorax. 1996 Jun;51(6):557–560. doi: 10.1136/thx.51.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Osann K. E. Epidemiology of lung cancer. Curr Opin Pulm Med. 1998 Jul;4(4):198–204. doi: 10.1097/00063198-199807000-00002. [DOI] [PubMed] [Google Scholar]
  22. Osterlind K., Hansen H. H., Hansen M., Dombernowsky P., Andersen P. K. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol. 1986 Sep;4(9):1307–1313. doi: 10.1200/JCO.1986.4.9.1307. [DOI] [PubMed] [Google Scholar]
  23. Peto R., Darby S., Deo H., Silcocks P., Whitley E., Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000 Aug 5;321(7257):323–329. doi: 10.1136/bmj.321.7257.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peto R., Darby S., Deo H., Silcocks P., Whitley E., Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000 Aug 5;321(7257):323–329. doi: 10.1136/bmj.321.7257.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302. [DOI] [PubMed] [Google Scholar]
  26. Rowell N. P., Williams C. J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001 Aug;56(8):628–638. doi: 10.1136/thorax.56.8.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Souhami R. L., Spiro S. G., Rudd R. M., Ruiz de Elvira M. C., James L. E., Gower N. H., Lamont A., Harper P. G. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst. 1997 Apr 16;89(8):577–580. doi: 10.1093/jnci/89.8.577. [DOI] [PubMed] [Google Scholar]
  29. Spiro S. G. Clinical trials in lung cancer: nihilism versus enthusiasm. Thorax. 1997 Jul;52(7):598–604. doi: 10.1136/thx.52.7.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stephens R. J., Parmar M. K., Souhami R. L., Spiro S. Chemotherapy in non-small cell lung cancer. Large trial will reduce uncertainty. Steering Committee of the Big Lung Trial. BMJ. 1996 Jan 27;312(7025):248–249. doi: 10.1136/bmj.312.7025.248c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Swensen Stephen J., Jett James R., Sloan Jeff A., Midthun David E., Hartman Thomas E., Sykes Anne-Marie, Aughenbaugh Gregory L., Zink Frank E., Hillman Shauna L., Noetzel Gayle R. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002 Feb 15;165(4):508–513. doi: 10.1164/ajrccm.165.4.2107006. [DOI] [PubMed] [Google Scholar]
  32. Tovar E. A. One-day admission for major lung resections in septuagenarians and octogenarians: a comparative study with a younger cohort. Eur J Cardiothorac Surg. 2001 Sep;20(3):449–454. doi: 10.1016/s1010-7940(01)00835-1. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES